Discussion Topic:Â Asundexian versus Apixaban in Patients with Atrial Fibrillation
Join moderator Melissa Middeldorp as she discusses the NEJM article Asundexian versus Apixaban in Patients with Atrial Fibrillation with Christopher C Cheung, MD, MPH and Prashanthan Sanders, MBBS, PhD, FHRS at HRS2024 in Atalnta. Brought to you live from the HRSTV Studio, this episode comes with bonus video footage.
Host:Â Melissa E. Middeldorp, MPH, PhD
Guests:Â Christopher C Cheung, MD, MPH and Prashanthan Sanders, MBBS, PhD, FHRS
Speaker and Article Information:Â Download
**View bonus video footage from HRX 2024 in Atlanta while listening on HRS365!
Topic
- The Lead
Resource Type
- Podcasts
Related Resources
The Lead
Podcasts
The Lead Episode 149: Heart Rhythm 2026 Late-Breaker Coverage: A Discussion of Safety and Performance of a Novel ICD Lead for Left Bundle Branch Area Pacing: Results from the ASCEND CSP Trial
Welcome to the latest episode of late-breaker coverage from Heart Rhythm 2026…
May 14, 2026
The Lead
Podcasts
The Lead Episode 150: Heart Rhythm 2026 Late-Breaker Coverage: A Discussion of Total Fatal Adverse Events Following Atrial Fibrillation Ablation Reported in an FDA Mandatory Reporting System: A Matter of Concern? The TiFFANY Study
This discussion reviews the late-breaking HRS 2026 study Total Fatal Adverse Events Following…
May 14, 2026
The Lead
Podcasts
The Lead Episode 148: The Lead Episode 148: HRS 2026 Late-Breaker Coverage, A Discussion of Ventricular Intramyocardial Navigation and Tachycardia Ablation Guided by Electrograms (VINTAGE): First-in-Human Experience with a Novel Therapy for Refractory Ventricular Arrhythmias
Join Digital Education Committee member Jason T. Jacobson, MD, FHRS, and his…
May 14, 2026